Bill Ackman Calls AI’s Rare-Disease Breakthrough ‘Incredible’ After Model Finds Drug Combination for Dying Patient

Bill Ackman, CEO of Pershing Square, praised an AI system that identified a novel drug combination for a 37-year-old patient with POEMS syndrome, who had been sent to hospice. The patient responded positively to the treatment within a week and later achieved remission after a stem cell transplant. This case exemplifies the potential of AI in drug repurposing, highlighting its ability to analyze existing medications for new therapeutic uses.